MedTrace Logo

Postnatal mHealth Intervention Development

NCT04636398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-06-04

Study results available
· View outcomes & findings →

Summary

This study is a six-week exploratory developmental phase (phase 1) of a larger project to develop an mHealth intervention targeting health education and social support for Indian women in the postnatal period. Phase 1 of the trial exposes study participants to various intervention modalities and seeks to understand their experiences and perspectives on these using mixed-methods. Results from this trial will inform modifications to the intervention to be tested in Phase 2.

Conditions

Interventions

BEHAVIORAL

MESSAGE - mHealth intervention

A group-based moderated six-week intervention with didactic, discussion, and text communication components.

Sponsors & Collaborators

  • University of California, Los Angeles

    collaborator OTHER

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    collaborator OTHER

  • Indraprastha Institute of Information Technology Delhi

    collaborator OTHER

  • Survival for Women and Children Foundation

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Alison El Ayadi, ScD · University of California, San Francisco

  • Nadia G Diamond-Smith, PhD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-01-30
Completion
2021-01-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636398 on ClinicalTrials.gov